Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-11 | OrbiMed Advisors LLCUnternehmen | 1,25M | 0,00 | Open Market Derivative Acquisition | 0,00 | 5,30M | 30,83% |
| 2026-06-09 | Dr. Clay B. SiegallIndependent Director | 62,50k | 250,00k | Kauf | 4,00 | 318,61k | 24,40% |
| 2026-05-22 | Dr. Clay B. SiegallIndependent Director | 128,05k | 138,89k | Derivative Exercise and Retained Stock | 1,08 | 256,11k | 100,00% |
| 2026-05-21 | Dr. Abhinav A. ShuklaChief Technical Officer | 5,12k | 5,56k | Derivative Exercise and Retained Stock | 1,08 | 63,14k | 8,83% |
| 2026-05-12 | Dr. Abhinav A. ShuklaChief Technical Officer | -2,03k | 6,99k | Derivative Exercise and Sale | 3,57 - 7,01 | 58,02k | - |
| 2026-05-12 | Dr. Arunthathy Nirmalini PanditeChief Medical Officer | -30,00k | 198,30k | Automatic Disposition | 6,61 | 166,22k | -15,29% |
| 2026-05-12 | Dr. Taylor H. SchreiberCo-Founder, CEO & Director | 25,61k | 27,78k | Derivative Exercise and Retained Stock | 1,08 | 2,73M | 0,95% |
| 2026-05-10 | Dr. Stephen StoutGeneral Counsel, Corporate Secretary and Chief Ethics & Compliance Officer | -968,00 | 6,63k | Sale to Issuer | 6,85 | 80,56k | -1,19% |
| 2026-01-25 | Dr. Arunthathy Nirmalini PanditeChief Medical Officer | -3,20k | 13,26k | Sale to Issuer | 4,15 | 163,51k | -1,92% |
| 2026-01-25 | Dr. Stephen StoutGeneral Counsel, Corporate Secretary and Chief Ethics & Compliance Officer | -593,00 | 2,46k | Sale to Issuer | 4,15 | 81,53k | -0,72% |
| 2026-01-25 | Ms. Casi DeYoungChief Business Officer | -2,29k | 9,49k | Sale to Issuer | 4,15 | 43,61k | -4,98% |
| 2026-01-25 | Mr. Andrew R. NeillCFO | -2,59k | 10,74k | Sale to Issuer | 4,15 | 191,24k | -1,34% |
| 2026-01-10 | Dr. Stephen StoutGeneral Counsel, Corporate Secretary and Chief Ethics & Compliance Officer | -4,15k | 19,73k | Sale to Issuer | 4,75 | 82,12k | -4,81% |
| 2026-01-10 | Ms. Casi DeYoungChief Business Officer | -5,70k | 27,07k | Sale to Issuer | 4,75 | 39,12k | -12,72% |
| 2026-01-10 | Dr. Arunthathy Nirmalini PanditeChief Medical Officer | -6,85k | 32,54k | Sale to Issuer | 4,75 | 157,24k | -4,18% |
| 2026-01-10 | Mr. Andrew R. NeillCFO | -6,66k | 31,64k | Sale to Issuer | 4,75 | 185,10k | -3,47% |
| 2025-08-25 | OrbiMed Advisors LLCUnternehmen | 5,10M | 0,00 | Open Market Derivative Acquisition | 0,00 - 1,08 | 3,07M | -251,97% |
| 2025-08-25 | OrbiMed Advisors LLCUnternehmen | 1,05M | 911,97k | Kauf | 0,87 | 1,05M | - |
| 2025-08-25 | OrbiMed Private Investments IX, LPUnternehmen | 5,26M | 4,56M | Kauf | 0,87 | 5,26M | - |
| 2025-08-25 | OrbiMed Private Investments IX, LPUnternehmen | 25,48M | 0,00 | Open Market Derivative Acquisition | 0,00 - 1,08 | 15,37M | -251,97% |
| 2025-08-25 | Dr. Stephen StoutGeneral Counsel, Corporate Secretary and Chief Ethics & Compliance Officer | 12,81k | 11,11k | Kauf | 0,87 | 86,28k | 17,43% |
| 2025-08-25 | Dr. Clay B. SiegallIndependent Director | 128,05k | 111,11k | Kauf | 0,87 | 128,05k | - |
| 2025-08-25 | Mr. Andrew R. NeillCFO | 64,03k | 55,56k | Kauf | 0,87 | 169,30k | 60,82% |
| 2025-08-25 | Dr. Taylor H. SchreiberCo-Founder, CEO & Director | 25,61k | 22,22k | Kauf | 0,87 | 2,71M | 0,95% |
| 2025-08-25 | Dr. Abhinav A. ShuklaChief Technical Officer | 5,12k | 4,44k | Kauf | 0,87 | 37,56k | 15,79% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
